CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.
CervoMed has raised $10.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
CervoMed's investors include RA Capital Management, Soleus Capital, Armistice Capital, Joshua Boger, Special Situations Funds.
CervoMed is headquartered in Boston, United States.
CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.
CervoMed is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CervoMed — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/cervomed. Accessed August 13, 2026.
VCBacked. (2026). CervoMed — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cervomed
{{cite web |title=CervoMed — Funding & Investors |url=https://www.vcbacked.co/company/cervomed |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated